Search results
-
Dr Ashray Gunjur
I am an early-career medical oncologist from Melbourne, Australia. I am broadly interested in immuno-oncology and the link between cancer and the gut microbiome, and am undertaking a PhD supervised by Dr David Adams and Dr Trevor Lawley (Wellcome...
-
Dr Alasdair Russell
... of state-of-the-art Genome Editing technologies to complex, patient-relevant model systems in a pre-clinical setting. Further, we use these ...
-
Dr Anna Piskorz
... prognostic and predictive biomarkers, helping in better patient stratification, earlier disease diagnosis, monitoring patient response and improving patient management during the course of ...
-
Miss Annalisa Occhipinti
I am a Mathematician and I am doing a PhD in bioinformatics at the University if Cambridge. I am currently working on gene network interactions and cancer data analysis. I am also developing a mathematical model of breast cancer, trying to link the gene...
-
Dr Andre Neves
... enable clinicians to assess more accurately and rapidly the patient's response to cancer therapies, potentially leading to better outcomes ...
-
Professor Brian Huntly
... and functional analyses of both mouse models and primary patient material. We are concentrating on transcriptional alterations in the ...
-
Professor Charlotte Coles
... avoidance of radiotherapy in minimal risk women: patient selection using biomarkers – open: 50+ UK centres to date 4. ...
-
Dr Pippa Corrie
My research is based on improving outcomes for patients with chemoresistant cancers. I am chief investigator of the national adjuvant melanoma phase 3 trial, collaborating with Mark Middleton, Oxford, who leads associated translational studies focusing...
-
Professor Chris Rodgers
... translating them into clinical research and ultimately for patient benefit. We are actively working on new methods parallel transmit ...
-
Ms Ceilidh Welsh
I am a PhD student working with Cancer Research UK RadNet Cambridge Radiation Research Centre of Excellence. My area of research looks into the development of novel machine-learning approaches for prediction of tumour control and normal-tissue...
-
Mr Aman Coonar
... PI for PULMICC study- a RCT of metastectomy v best other care for colorectal metastases to lung. ...
-
Dr Anny Wong
... and investigations. She also specialises in the follow-up care of children who have finished their cancer treatment. ...
-
Dr Catherine Green
I run a small group in the Department of Zoology funded by a Cancer Research UK career development fellowship. We are investigating the mechanisms and control of genome replication, both at genetic and epigenetic levels. It is during replication that...
-
Professor Fiona Gilbert
... radiotracers which may be valuable as biomarkers for patient care or in drug development. ...
-
Dr Helen Morris
In the Primary Care Unit I've managed and collaborated on a number of randomised controlled ... studies in the field of cancer and genetics in a primary care setting: 1) The GRAIDS (Genetic Risk Assessment on the Internet and ... the management of suspicious pigmented lesions in primary care, CI Dr F Walter; 3) BEST (Barrett's Oesophagus Screening Trial), CI Dr R ...
-
Professor James Brenton
Ovarian cancer has a disproportionately high health care burden because of low cure rates and frequent symptoms caused by recurrent ...
-
Dr Juliet Usher-Smith
My research focuses on the use of risk prediction models to promote behaviour change to help prevent cancer and inform stratified screening programmes.
-
Dr Kelly Fagan Robinson
... hierarchies, education, and experiences of formalised care can generate epistemic dissonances and injustices for British people. ... populations within the contexts of cancer, risk and care. This project has facilitated greater understanding of various ...
-
Dr Kyren Lazarus
My overall career ambition is to develop novel insights into breast cancer pathology to help improve clinical outcomes for sufferers. I will be working with Dr Walid Khaled in order to understand transcriptional regulation of cell fate in mammary...
-
Dr James Nicholson
... are in germ cell tumours and he chairs the national childrens germ cell tumour NCRI subgroup, working closely with European and ...
-
Dr Ali Amin Al Olama
... has focused on discovery of genetic risk factors of prostate cancer through genome-wide association studies and fine-mapping. I am a core member of an international consortium PRACTICAL (Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the ...
-
Dr Andreas Bender
... large amounts of chemical or biological data related to cancer drug discovery you are very welcome to contact me to see in which way I ...
-
Dr Alejandra Bruna
... aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in ... of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the molecular heterogeneity present in primary ...
-
Professor Antonis Antoniou
... component; - the identification and characterisation of cancer risks for genetically susceptible individuals, such as those carrying ...
-
Dr Catherine Lindon
... to coordinated cell division, and have well documented cancer-promoting activities. Ongoing projects in the lab explore how ... in time and space, and how their activity contributes to cancer. We have recently described a 'ubiquitome' of cellular components ...
-
Dr Alison Dunning
Work in the Centre for Cancer Genetic Epidemiology "wet lab" involves running very high throughput ... (NGS) studies. We search for genetic risk factors for both cancer susceptibility and treatment-response. In this we collaborate closely ... consortia for breast, ovarian, endometrial and prostate cancer association studies: BCAC http://bcac.ccge.medschl.cam.ac.uk, CIMBA ...
-
Dr Ahsan MEMON
... this holographic system was deployed to the study of cancer and stem cell shape regulation and the role of effective membrane ...
-
Dr Aisling Redmond
... She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK Cambridge Institute (with Professor Jason Carroll), ...
-
Professor Alan Warren
... how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome, containing ... it is also important for oncogenesis: a novel class of human cancer predisposition disorder has recently emerged that is caused by mutations ...
-
Professor Bertie Gottgens
... cells and how mutations that perturb such networks cause leukaemia. This integrated approach has resulted in the discovery of new ... transcriptional consequences of leukaemogenic mutations in leukaemia stem/progenitor cells, and (iv) molecular characterisation of human ...
-
Dr Joanna Baxter
The Cambridge Blood and Stem Cell Biobank is a facility of over 6000 viable and nucleic acid samples, the majority from patients with haematological malignancy and clonal blood cell disorders; and the remainder, around 20%, from normal individuals,...
-
Dr Elisa Laurenti
... of HSC regulatory networks drives the first steps of leukaemia, knowledge of HSC specific molecular responses will prove important ...
-
Professor Guy Brown
... Mitochondria, nitric oxide & cell death. (iii) Cell death in leukaemia. ...
-
Professor George Vassiliou
... malignancies with a particular focus on acute myeloid leukaemia (AML). I am also a Consultant Haematologist at Addenbrooke's Hospital ...
-
Professor Jasmin Fisher
... during development and cancer (e.g., Chronic Myeloid Leukaemia, breast cancer, glioblastoma). These models are essentially computer ...
-
Professor Marc Tischkowitz
... gene mutations in the development of sporadic acute myeloid leukaemia. He held a Consultant post at Great Ormond Street Hospital before ...